Cargando…
The Combination of Three Components Derived from Sheng MaiSan Protects Myocardial Ischemic Diseases and Inhibits Oxidative Stress via Modulating MAPKs and JAK2-STAT3 Signaling Pathways Based on Bioinformatics Approach
GRS is a drug combination of three components including ginsenoside Rb1, ruscogenin and schisandrin. It derived from the well-known TCM formula Sheng MaiSan, a widely used traditional Chinese medicine for the treatment of cardiovascular diseases in clinic. The present study illuminates its underlyin...
Autores principales: | Li, Fang, Zhang, Yu, Zeng, Donglin, Xia, Yu, Fan, Xiaoxue, Tan, Yisha, Kou, Junping, Yu, Boyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282471/ https://www.ncbi.nlm.nih.gov/pubmed/28197101 http://dx.doi.org/10.3389/fphar.2017.00021 |
Ejemplares similares
-
Extract of Sheng-Mai-San Ameliorates Myocardial Ischemia-Induced Heart Failure by Modulating Ca(2+)-Calcineurin-Mediated Drp1 Signaling Pathways
por: Yang, Ye, et al.
Publicado: (2017) -
Cardioprotection by combination of three compounds from ShengMai preparations in mice with myocardial ischemia/reperfusion injury through AMPK activation-mediated mitochondrial fission
por: Li, Fang, et al.
Publicado: (2016) -
Protective Effects of Sheng-Mai-San on Right Ventricular Dysfunction during Chronic Intermittent Hypoxia in Mice
por: Chai, Cheng-Zhi, et al.
Publicado: (2016) -
Sheng Mai San protects H9C2 cells against hyperglycemia-induced apoptosis
por: Pang, Bing, et al.
Publicado: (2019) -
ShengMai-San Attenuates Cardiac Remodeling in Diabetic Rats by Inhibiting NOX-Mediated Oxidative Stress
por: Lu, Yanting, et al.
Publicado: (2021)